PRIMECAP Odyssey Aggressive Growth (M:POAGX)

Add to Watchlists
Create an Alert
48.89 +0.74  +1.54% Feb 23 USD
View Full Chart
M:POAGX Total Returns Chart

M:POAGX Key Stats

M:POAGX Performance

  Total Return (Price) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 0.18% -3.75% 3
3M 11.46% 4.02% 2
6M 30.83% 13.28% 1
YTD 10.29% 2.19% 2
1Y 39.93% 18.51% 1
3Y 17.84% 8.51% 1
5Y 23.28% 12.77% 1
10Y 17.36% 9.00% 1
As of Feb. 23, 2018. Returns for periods of 1 year and above are annualized.

M:POAGX Asset Allocation

Type % Net % Long % Short
Cash 1.87% 1.87% 0.00%
Stock 97.85% 97.85% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.28% 0.28% 0.00%
Other 0.00% 0.00% 0.00%
As of Dec. 31, 2017

M:POAGX Region Exposure

Americas 91.47%
North America 91.47%
Latin America 0.00%
Greater Europe 1.64%
United Kingdom 0.06%
Europe Developed 1.09%
Europe Emerging 0.00%
Africa/Middle East 0.49%
Greater Asia 6.89%
Japan 3.54%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 3.36%
Market Classification
% Developed Markets 96.64%
% Emerging Markets 3.36%
As of Dec. 31, 2017. Region breakdown data is calculated by using the long position holdings of the portfolio.

M:POAGX Stock Sector Exposure

Basic Materials 0.41%
Communication Services 1.49%
Consumer Cyclical 11.65%
Consumer Defensive 1.45%
Energy 0.35%
Financial Services 3.76%
Healthcare 34.11%
Industrials 14.86%
Real Estate 0.00%
Technology 31.93%
Utilities 0.00%
As of Dec. 31, 2017

M:POAGX Stock Market Capitalization

Giant 10.16%
Large 23.71%
Medium 43.69%
Small 12.38%
Micro 10.06%
As of Dec. 31, 2017

M:POAGX Stock Style Exposure

Large Cap Value 10.86%
Large Cap Blend 14.12%
Large Cap Growth 8.76%
Mid Cap Value 4.97%
Mid Cap Blend 18.29%
Mid Cap Growth 20.47%
Small Cap Value 2.58%
Small Cap Blend 3.75%
Small Cap Growth 16.20%
As of Dec. 31, 2017
View More Holdings

M:POAGX Top 10 Holdings

Symbol Name % Weight Price % Chg
NKTR Nektar Therapeutics Inc 8.16% 89.60 +1.58%
SNE Sony Corp ADR 3.46% 50.23 +0.76%
ABMD Abiomed Inc 3.45% 268.45 +1.70%
ALKS Alkermes PLC 3.42% 58.60 +3.63%
AAL American Airlines Group Inc 2.92% 53.39 +0.77%
MU Micron Technology Inc 2.87% 46.53 +5.15%
BB BlackBerry Ltd 2.71% 12.55 +5.37%
UAL United Continental Holdings Inc 2.31% 67.57 +1.30%
DAL Delta Air Lines Inc 2.18% 53.46 +1.73%
SGEN Seattle Genetics Inc 2.13% 55.35 +2.92%
As of Dec. 31, 2017
Advertisement

M:POAGX One Page Reports

M:POAGX Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class US Equity
Broad Category Equity
Category Name Mid-Cap Growth
Prospectus Objective Aggressive Growth
Fund Owner Firm Name PRIMECAP Odyssey Funds
Benchmark Index
S&P 500 TR USD
100.0%

M:POAGX Manager Info

Name Tenure
Alfred Mordecai 12.92 yrs
James Marchetti 2.92 yrs
Joel Fried 12.92 yrs
M. Ansari 5.47 yrs
Theo Kolokotrones 12.92 yrs

M:POAGX Net Fund Flows

1M 35.48M
3M 12.12M
6M -38.71M
YTD 35.48M
1Y 83.60M
3Y -183.81M
5Y 2.128B
10Y 3.379B
As of Jan. 31, 2018

M:POAGX Risk Info

Beta (5Y) 1.166
Historical Sharpe (10Y) 0.916
Historical Sortino (All) 1.082
Daily Value at Risk (VaR) 1% (All) 3.56%
Monthly Value at Risk (VaR) 1% (All) 17.41%

M:POAGX Fundamentals

Dividend Yield TTM (2-23-18) 0.00%
SEC Yield --
Weighted Average PE Ratio 21.14
Weighted Average Price to Sales Ratio 2.099
Weighted Average Price to Book Ratio 3.802
Weighted Median ROE 9.90%
Weighted Median ROA 0.71%
Forecasted Dividend Yield 0.41%
Forecasted PE Ratio 17.57
Forecasted Price to Sales Ratio 2.116
Forecasted Price to Book Ratio 3.140
Number of Holdings 156
As of Dec. 31, 2017

M:POAGX Growth Estimates

Forecasted 5 Yr Earnings Growth 10.61%
Forecasted Book Value Growth 1.20%
Forecasted Cash Flow Growth 17.02%
Forecasted Earnings Growth 3.68%
Forecasted Revenue Growth -1.51%
As of Dec. 31, 2017

M:POAGX Comparables

Edit

M:POAGX Attributes

Purchase Details
Open to New Investors No
Open to Existing Investors Yes
Minimum Initial Investment 2000.00 USD
Minimum Subsequent Investment 100.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.55%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 11/1/2004
Termination Date
Last Annual Report Date 10/31/2017
Last Prospectus Date 10/31/2017
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

M:POAGX Excel Add-In Codes

  • Name: =YCI("M:POAGX","name")
  • Broad Asset Class: =YCI("M:POAGX", "broad_asset_class")
  • Broad Category: =YCI("M:POAGX", "broad_category_group")
  • Prospectus Objective: =YCI("M:POAGX", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.